August is National Immunization Awareness Month. It’s the perfect time to discuss immunizations with patients who come in to pick up their regular prescriptions. Many people are under the impression that vaccines are just for children, but the fact is that adults are just as susceptible to many conditions. Vaccinations are important year round, not […]
In late June, MannKind Corp. announced the FDA approved their product, an inhaled form of insulin, known as Afrezza.
In July, Bristol-Myers Squibb announced the recall of some of their 5 mg single-use Coumadin injections. Six lots are affected in the recall: 00201125, 00201126, 00201127, 00201128, 00201129, and 00201130. The voluntary nationwide recall is a result of visible particulate matter found in some unreleased samples. These lots were distributed in six-count cartons to pharmacies […]
In 2012, the FDA required a warning and additional contraindication in labeling for any products that contained codeine. This was designed to discourage doctors from prescribing the medications for post-surgery pain relief in children who’d just had a tonsillectomy or adenoidectomy.
For over 10 years, pharmacists at Iowa Methodist Medical Center have tested patients for penicillin sensitivity. The program hasn’t always run smoothly, but it works in an effort to avoid treating with more expensive medications, and medications that often have more serious side effects.
On May 20, 2014, Takeda Pharmaceutical Company Limited and the FDA announced vedolizumab as a treatment option for moderate to severe ulcerative colitis (UC) and Crohn’s disease (CD) for adults whose illness did not respond to or tolerate other treatment options. Specifically, the labeling for this monoclonal antibody therapy indicates it is for use with […]
Every year, more than 1 million people suffer from an eye injury, and many of those injuries could have been prevented with the use of appropriate protective eye wear. When dealing with a patient who has experienced an eye injury, it is important to look for signs of more serious injury that requires immediate medical […]
In 2013, 432 million prescriptions were written for low testosterone treatment solutions. 2.9% of American men aged 40 or older are using prescription treatments, spending $1.6 billion a year on the medications. Some younger men are taking testosterone replacement therapy drugs in an effort to prevent the natural decline in testosterone levels associated with aging.
